iBio, Inc
Financing
SEC filings to 2026-10-05 · every row opens its filingShares on issue
55.7M
on 2026-06-30, from 8.52M on 2024-03-31 10-K ↗
a raise that quarter, at its price
$100.0M
Jefferies, agreement of 2026-02-27. No at-the-market sales statement read from a 10-Q or 10-K. 424B5 ↗
Warrants
The 10-K filed 2026-08-28 is not read yet.
Cash
15.2 quarters
$88.0M on 2026-06-30 ÷ $5.8M a quarter of operating cash used, the average of four quarters. 10-K ↗
| Date | What | Shares | Price | Gross | Filing |
|---|---|---|---|---|---|
| 2026-01-08 | Private placement incl. 9.65M pre-funded | 11,061,738 | not read | $26.0M | 8-K ↗ |
| 2025-08-19 | Public offering | not read | $0.699 | $50.0M | 424B5 ↗ |
| 2025-04-29 | Public offering incl. 1.83M pre-funded | 3,365,385 | not read | not read | 424B5 ↗ |
| 2025-04-29 | Public offering incl. 1.65M pre-funded | 2,250,000 | not read | not read | 424B5 ↗ |
| 2025-04-29 | Public offering | 10,574,556 | not read | not read | 424B5 ↗ |
| 2025-01-10 | Private placement | 240,807 | not read | $655K | 8-K ↗ |